No Data
No Data
Chemclin Diagnostics Co., Ltd.'s (SHSE:688468) Share Price Boosted 36% But Its Business Prospects Need A Lift Too
Komei Diagnostic Technology Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Komei Diagnostic Technology Co., Ltd.
Kemei Diagnosis (688468.SH): has repurchased 1.62% of the company's shares.
As of July 31st, 2024, Kemei Diagnostic (688468.SH) announced that it has repurchased a total of 6.5149 million shares of the company through the Shanghai Stock Exchange trading system by means of centralized bidding trading, accounting for 1.62% of the total share capital of 401,108,000 shares. The highest and lowest transaction prices for the buyback were 10.30 yuan/share and 5.83 yuan/share, respectively. The company has paid a total of 51.0751 million yuan (excluding stamp duty, trading commission and other transaction costs).
BT Financial Report Instant Analysis: In the first quarter of 2024, Kemei Diagnostics achieved double growth in revenue and net income, and significant improvement in cash flow.
As a professional medical diagnostic solution provider with the stock code of 688468, Kemei Diagnostic Technology Co., Ltd. recently released its Q1 2024 financial report. The report shows that the company has demonstrated a steady growth trend in multiple critical financial indicators. First of all, looking at the asset-liability data, Kemei Diagnostic's total asset size has slightly decreased, with an ending balance of 1.819 billion yuan, a decrease of 0.07% compared to the end of the previous year. This is mainly due to the company's optimization of asset allocation and reduction of non-core asset holdings. At the same time, the total equity belonging to shareholders of the listed company has also decreased.
Kemei Diagnosis (688468.SH): Did not buy back company shares in June.
On June 28th, GE Healthcare announced that the company did not repurchase its own shares through competitive bidding on the Shanghai Stock Exchange trading system in June 2024. As of June 28th, 2024, the company has repurchased a total of 6,514,913 shares of the company through centralized bidding trading on the Shanghai Stock Exchange trading system, accounting for 1.62% of the company's total share capital of 401,108,000 shares. The highest repurchase price was 10.30 yuan/share, the lowest repurchase price was 5.83 yuan/share, and the total amount paid was CNY 51,075.
No Data
No Data